• Je něco špatně v tomto záznamu ?

Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype

Y. Mazurová, I. Gunčová, I. Látr, E. Rudolf

. 2011 ; 10 (4) : 486-499.

Jazyk angličtina Země Spojené arabské emiráty

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022189

The evidence for the existence of neurogenesis in the adult mammalian brain, including humans is now widely accepted. Despite the fact that adult neural stem cells appear to be very promising, a wide range of their unrevealed properties, abilities but also limitations under physiological and especially pathological conditions still need to be investigated and explained. Huntington's disease (HD) is characterized by successive degeneration of relatively well-defined neuronal population. Moreover, the most affected region, the caudate nucleus, is adjacent to the subependymal zone (SEZ) neurogenic region. Therefore, the possibility to harness the endogenous neural stem cell capacity for repairing, or at least restricting, the fatal neurodegenerative process in HD patients using promoted neurogenesis in the adult SEZ represent the exciting new possibility in clinical management of this disorder. On the other hand, many questions have to be answered before neuronal replacement therapies using endogenous precursors become a reality, particularly in relation to neurodegenerative diseases. Fundamental for all experimental, functional and future clinical studies is detailed morphological description of structures involved in the process of neurogenesis. The objectives of this review are to describe neurogenesis in the adult murine and human brain (with particular emphasis to morphological aspects of this process) and to determine to what extent it is affected in animal models of HD and in the human HD brain. Due to very limited evidence referring to the impact of striatal pathology of HD phenotype on the adult neurogenesis in the SEZ, some results gained from our studies on two rat models of HD, i.e. the neurotoxic lesion and transgenic HD rats, and on human HD brains are discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022189
003      
CZ-PrNML
005      
20160304124258.0
007      
ta
008      
120806s2011 ts f 000 0#eng||
009      
AR
024    7_
$a 10.2174/187152711795563967 $2 doi
035    __
$a (PubMed)21495959
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Mazurová, Yvona, $u Department of Histology and Embryology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Simkova 870, P.O. Box 38, 500 38 Hradec Králové, Czech Republic $d 1951- $7 xx0054511
245    10
$a Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype / $c Y. Mazurová, I. Gunčová, I. Látr, E. Rudolf
520    9_
$a The evidence for the existence of neurogenesis in the adult mammalian brain, including humans is now widely accepted. Despite the fact that adult neural stem cells appear to be very promising, a wide range of their unrevealed properties, abilities but also limitations under physiological and especially pathological conditions still need to be investigated and explained. Huntington's disease (HD) is characterized by successive degeneration of relatively well-defined neuronal population. Moreover, the most affected region, the caudate nucleus, is adjacent to the subependymal zone (SEZ) neurogenic region. Therefore, the possibility to harness the endogenous neural stem cell capacity for repairing, or at least restricting, the fatal neurodegenerative process in HD patients using promoted neurogenesis in the adult SEZ represent the exciting new possibility in clinical management of this disorder. On the other hand, many questions have to be answered before neuronal replacement therapies using endogenous precursors become a reality, particularly in relation to neurodegenerative diseases. Fundamental for all experimental, functional and future clinical studies is detailed morphological description of structures involved in the process of neurogenesis. The objectives of this review are to describe neurogenesis in the adult murine and human brain (with particular emphasis to morphological aspects of this process) and to determine to what extent it is affected in animal models of HD and in the human HD brain. Due to very limited evidence referring to the impact of striatal pathology of HD phenotype on the adult neurogenesis in the SEZ, some results gained from our studies on two rat models of HD, i.e. the neurotoxic lesion and transgenic HD rats, and on human HD brains are discussed.
650    _2
$a zvířata $7 D000818
650    _2
$a nucleus caudatus $x patologie $x patofyziologie $7 D002421
650    _2
$a buněčná diferenciace $x fyziologie $7 D002454
650    _2
$a proliferace buněk $7 D049109
650    _2
$a lidé $7 D006801
650    _2
$a Huntingtonova nemoc $x patologie $x patofyziologie $x terapie $7 D006816
650    _2
$a savci $7 D008322
650    _2
$a degenerace nervu $x patologie $7 D009410
650    _2
$a nervové kmenové buňky $x fyziologie $x transplantace $7 D058953
650    _2
$a neurogeneze $x fyziologie $7 D055495
650    _2
$a neurony $x patologie $x fyziologie $7 D009474
650    _2
$a fenotyp $7 D010641
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Němečková, Ivana $7 xx0208646
700    1_
$a Látr, Ivan, $d 1943- $7 xx0062309
700    1_
$a Rudolf, Emil, $d 1970- $7 xx0076300
773    0_
$w MED00173402 $t CNS & neurological disorders drug targets $x 1996-3181 $g Roč. 10, č. 4 (2011), s. 486-499
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21495959 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20160304124310 $b ABA008
999    __
$a ok $b bmc $g 944102 $s 779486
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 10 $c 4 $d 486-499 $i 1996-3181 $m CNS & neurological disorders. Drug targets $n CNS Neurol Disord Drug Targets $x MED00173402
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...